Genea Biomedx creates vitrification and incubation platforms for Assisted Reproductive Technology and In-Vitro Fertilisation (ART, IVF), distributing through one of the world’s biggest pharmaceutical companies. Genea Biomedx IVF tracking market is worth US$20 million. It plans to launch product soon through a major global pharmaceutics partner.Visit Genea Biomedx >
Planet Innovation is a design house which was awarded Australia’s ‘Most Innovative Company’ for five consecutive years. Planet Innovation’s cryogenic cold chain logistics market is US$30 million, alongside adjacent opportunities.Visit Planet Innovation >
Labcon is a large plastic labware manufacturer based in San Francisco, moulding more than 1.4 billion consumables each year. Its bio-preservation market is estimated at US$200 million, with US$40 million of that being in 2ml vials.Visit Labcon >
Bluechiip has several reference sites where Bluechiip is operating:
- Institute of Molecular Bioscience, CRC Autism, Brisbane, Queensland, AUS
- Centre for Disease and Control, Beijing, CN
- Southern Research, Alabama, USA
Discounted products and evaluation trial packages are available for those who would like to become a "Bluechiip reference site". Contact us for more information.